1
0
0
(1 - 37 von 49
)
Monday16:00 Uhr: Hochdosistherapie und autologe...
www.lifescience.net
... (Privatdozentin Dr. Iris Breitkreutz, Universitätsklinikum Heidelberg, Sektion Multiples Myelom) (DE). None | Posted on Sep 18, Recommendations: n/a.
Heidelberg University: Details of event: Kardio-Onkologie: Eine neue...
veranstaltungskalender.urz.uni-heidelberg.de
Privatdozentin Dr. Iris Breitkreutz, Universitätsklinikum Heidelberg, Sektion Multiples Myelom. Friday 22nd November 2019, 04:30 PM. Vagale Dysfunktion bei Jugendlichen mit Depressionen. Privatdozent Dr. Julian König. Wednesday 27th November 2019, 06:00 PM. Okuläre Behandlung mit dem Cyclo G6 Micropulslaser
Биологические особенности трансформации плазматических клеток и...
medical-diss.com
Multiple myeloma / Marc S. Raab, Klaus Podar, Iris Breitkreutz, Paul G. Richardson, Kenneth C. Anderson // Lancet Vol P Hernandez, L. Palomera, D. Carrera, R. Martinez, J. De la Rubia, A. Martin, J. Blade, J J. Lahuerta, A. Orfao, J.F. San Miguel // Blood №10. -Vol P
外文检索-中国知网
scholar.cnki.net
Author：Iris Breitkreutz , Paul G Richardson. Data Source：[J].The Lancet(IF ), 2009, Vol.374 (9686), pp Elsevier. Abstract：Summary(#br)Multiple ...
Therapieoptimierung des Multiplen Myeloms - Iris Breitkreutz - Google...
books.google.de
Therapieoptimierung des Multiplen Myeloms. Front Cover. Iris Breitkreutz. Ruprecht-Karls-Universität Heidelberg, Reviews ...
Multiple Myeloma: Translational and Emerging Therapies
books.google.de
... Iris Breitkreutz, et al. Inhibition of ERK1/2 Activity by the MEK1/2 inhibitor AZD6244 (ARRY ) induces human multiple myeloma cell apoptosis in the ...
Multiple Myeloma: Translational and Emerging Therapies - Google Books
books.google.de
Multiple myeloma is the second most prevalent hematological malignancy, with over 55,000 new cases diagnosed each year. This exciting new text, edited by...
Immunomodulatory Drug Lenalidomide (CC-5013, IMiD3 ...
www.stevenptreon.com
Yu-Tzu Tai, 1Xian-Feng Li, Laurence Catley,1 Rory Coffey, Iris Breitkreutz, Jooeun Bae, 1Weihua Song, Klaus Podar, Teru Hideshima, Dharminder Chauhan, 1Robert Schlossman, Paul Richardson,1 Steven P. Treon, 1Iqbal S. Grewal,2 Nikhil C. Munshi, and Kenneth C. Anderson1 1Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, …
Big tranSMART for Clinical Decision Making - Spiral
spiral.imperial.ac.uk
[RPB+09] Marc S Raab, Klaus Podar, Iris Breitkreutz, Paul G Richardson, and Ken- neth C Anderson. Multiple myeloma. Lancet, 374:324–339, › bitstream › Wang-S-...
Immunomodulatory Drug Lenalidomide (CC-5013, IMiD3) ...AACR Journals ·
aacrjournals.org
von YT Tai · · Zitiert von: 207 — Iris Breitkreutz;. Iris Breitkreutz. 1Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical ... › ...
Dose‐intensified bendamustine followed by autologous peripheral blood...
www.deepdyve.com
peripheral blood stem cell support in relapsed and. refractory multiple myeloma with impaired bone marrow. function. Iris Breitkreutz. 1,2. , Natalia Becker. 3.
Suppressing miRNA-15a/-16 expression by interleukin-6 enhances...
jhoonline.biomedcentral.com
Raab MarcS, Klaus Podar, Iris Breitkreutz: Multiple myeloma. Lancet 2009, 374: PubMed Abstract | Publisher Full Text. Hardin J, MacLeod S, Grigorieva I, Chang
DISSERTATION HRAS GTPase, a novel regulator of bone ...Universität Ulm ·
oparu.uni-ulm.de
von S Nandi · · Zitiert von: 1 — differentiation and function in multiple myeloma (Iris Breitkreutz et al., 2007). PI3K/Akt pathway also plays a very critical role in osteoclastogenesis. › handle
Suppressing miRNA-15a/-16 expression by BioMedSearchwww.biomedsearch.com/attachments pdf
www.biomedsearch.com
Raab SMarc, Klaus Podar, Iris Breitkreutz: Multiple myeloma. Lancet 2009,. 374: Hardin J, MacLeod S, Grigorieva I, Chang R, ...
Download book from ISBN number Blutstammzelltransplantation
plaza.rakuten.co.jp
— :00 Uhr: Hochdosistherapie und autologe Blutstammzelltransplantation beim Multiplen Myelom (Privatdozentin Dr. Iris Breitkreutz, › diary
Thalidomide in newly diagnosed multiple myeloma: influence of ...www.nature.com › leukemia › original article › article
www.nature.com
· I Breitkreutz: Iris Breitkreutz, MD, performed this work at the University of Heidelberg, Department of Hematology/Oncology, INF 410, ...
Universitätsklinikum Heidelberg: Priv.-Doz. Dr. med. Iris Breitkreutz
www.bing.com
NettetPriv.-Doz. Dr. med. Iris Breitkreutz. Funktionsoberärztin (Myelomzentrum Heidelberg) Funktionsoberärztin (Multiples Myelom - Spezialsprechstunde/Casemanagement für …
Iris Breitkreutz
www.infona.pl
Search results for: Iris Breitkreutz ... Marc S Raab, Klaus Podar, Iris Breitkreutz, Paul G Richardson, more · The Lancet > > 374 > > Multiple ...
Multiples Myelom - Spezialsprechstunde/Casemanagement für …
www.bing.com
NettetPriv.-Doz. Dr. med. Iris Breitkreutz. E-Mail. Tina Harmon. Schwerpunkt. Neuanfragen Myelom-Patienten und Koordination der privat-Versicherten Myelom-Patienten E-Mail …
Multiple myeloma.Read by QxMD
read.qxmd.com
Marc S Raab, Klaus Podar, Iris Breitkreutz, Paul G Richardson, Kenneth C Anderson. Lancet July 26. Multiple myeloma is characterised by clonal ...
Patientenfibel Multiples Myelom Diagnostik und …
www.bing.com
NettetPD Dr. med. Iris Breitkreutz, Prof. Marc-Steffen Raab, Prof. Dr. med. Hartmut Goldschmidt, Universitätsklinikum Heidelberg, Medizinische Klinik V Die Forschung über das Multiple …
MLN3897, a novel CCR1 inhibitor, impairs osteoclastogenesis ...CiNii Research
cir.nii.ac.jp
von S Vallet · · Zitiert von: 153 — Iris Breitkreutz: Jerome Lipper Multiple Myeloma Disease Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA;.
Primärtherapie beim Multiplen MyelomDocPlayer.org
docplayer.org
Foto: wikipedia.org/kgh, CC BY-SA 3.0 Primärtherapie beim Multiplen Myelom PRIV.-DOZ. DR. IRIS BREITKREUTZ Medizinische Klinik V, Universitätsklinikum ...
Targeting PKC in multiple myeloma: in vitro and in vivo ...Altmetric
www.altmetric.com
Klaus Podar, Marc S. Raab, Jing Zhang, Douglas McMillin, Iris Breitkreutz, Yu-Tzu Tai, Boris K. Lin, Nikhil Munshi, Teru Hideshima, Dharminder Chauhan, ...
SAR directly induces multiple myeloma cell death via...
read.qxmd.com
Yu-Tzu Tai, Xian-Feng Li, Laurence Catley, Rory Coffey, Iris Breitkreutz, Jooeun Bae, Weihua Song, Klaus Podar, Teru Hideshima, Dharminder Chauhan, ...
Role of BAFF in Adhesion and Growth of Human Multiple ...ASH Publications
ashpublications.org
von YT Tai · — Iris Breitkreutz, MD,. Iris Breitkreutz, MD *. 1Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Karlsruher Virtueller Katalog KVKKarlsruhe Institute of Technology ·
kvk.bibliothek.kit.edu
The orally available multikinase inhibitor regorafenib (BAY ) in multiple myeloma / by Iris Breitkreutz, Klaus Podar, Vianihuini Figueroa-Vazquez, ... › ...
Multiple Myeloma A New Era Of Treatment Strategies By Klaus Podar -...
ujibahoqyt.ml
Marc S Raab, Klaus Podar, Iris Breitkreutz, Paul G Richardson, Kenneth C Anderson. Multiple myeloma However, the new era of treatment for ...
Suppressing miRNA-15a/-16 expression by CyberLeninkacyberleninka.org › article
cyberleninka.org
Raab SMarc, Klaus Podar, Iris Breitkreutz: Multiple myeloma. Lancet 2009, 374: Hardin J, MacLeod S, Grigorieva I, Chang R, Barlogie B, Xiao H, ...
Myeloma cellsSigma-Aldrich ·
www.sigmaaldrich.com
Results of — Iris Breitkreutz et al. Annals of hematology, 97(5), ( ). A promising approach to the treatment of multiple myeloma ... › ...
Regorafenib - Sigma-Aldrich
www.sigmaaldrich.com
Results of 101 — Iris Breitkreutz et al. Annals of hematology, 97(5), ( ). A promising approach to the treatment of multiple myeloma ... › re...
Preclinical efficacy of sepantronium bromide (YM155) in multiple...
www.oncotarget.com
https://doi.org oncotarget Verena Wagner, Dirk Hose, Anja Seckinger, Ludmila Weiz, Tobias Meißner, Thiery Rème, Iris Breitkreutz, Klaus Podar,...
Nefrología Básica 2. Capítulo. MANIFESTACIONES RENALES DE LOS...
docplayer.es
6 Bibliografía: MARC S. RAAB; Laus Podar, Iris Breitkreutz, Paul G. Richrdson, Kenneth C Anderson. Multiple myeloma. The Lancet 2009; 374, NELSON ...
Targeting PKC in multiple myeloma: in vitro and in vivo effects ...medchemexpress.cn ·
www.medchemexpress.cn
Klaus Podar 1, Marc S Raab, Jing Zhang, Douglas McMillin, Iris Breitkreutz, Yu-Tzu Tai, Boris K Lin, Nikhil Munshi, Teru Hideshima, Dharminder Chauhan, ... › ...
[First-line treatment of multiple myeloma]. - Semantic Scholar
www.semanticscholar.org
author={Iris Breitkreutz and Marc S Raab and Hartmut Goldschmidt}, journal={Der Internist}, year={2019}, volume={60 1}, pages={ } }. › ...
drug gene association prediction via text mining and ontologies
tud.qucosa.de
von M Kissa — Iris Breitkreutz and Kenneth C Anderson. Thalidomide in multiple myeloma – clinical trials and aspects of drug metabolism and toxicity. Expert Opinion on. › api › attachment › ATT-0
Alle Infos zum Namen "Iris Breitkreutz"
Verwandte Suchanfragen zu Iris Breitkreutz
| Thomas Hielscher Blanka Leber Hartmut Goldschmidt | Karin Jordan Klaus Podar Jens Hillengass | Douglas McMillin Natalia Becker Gerlinde Egerer |
Personen Vorname "Iris" (22276) Name "Breitkreutz" (181) |
sortiert nach Relevanz / Datum